• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷 Rh2 通过调控 CFAP20DC-AS1/miR-3614-3p/BBX 和 TNFAIP3 轴诱导乳腺癌细胞凋亡。

Ginsenoside Rh2 Regulates the CFAP20DC-AS1/MicroRNA-3614-3p/BBX and TNFAIP3 Axis to Induce Apoptosis in Breast Cancer Cells.

机构信息

Department of Life Science, Dongguk University-Seoul, Goyang, Republic of Korea.

出版信息

Am J Chin Med. 2022;50(6):1703-1717. doi: 10.1142/S0192415X22500720. Epub 2022 Jul 4.

DOI:10.1142/S0192415X22500720
PMID:35787669
Abstract

While a number of coding genes have explained the anticancer activity of ginsenoside Rh2, little is known about noncoding RNAs. This study was performed to elucidate the regulatory activity of long noncoding RNA (lncRNA) CFAP20DC-AS1, which is known to be downregulated by Rh2. MiR-3614-3p, which potentially binds CFAP20DC-AS1, was screened using the LncBase Predicted program, and the binding was verified by assaying the luciferase activity of a luciferase/lncRNA recombinant plasmid construct. The competitive endogenous RNA (ceRNA) relationship of the two RNAs was further validated by quantitative PCR after deregulation of each RNA using siRNA. The effect of miRNA and target genes on the MCF-7 cancer cell growth was determined by monitoring proliferation and apoptosis in the presence of Rh2 after deregulating the corresponding gene. The miRNA decreased the luciferase activity of the luciferase/CFAP20DC-AS1 fusion vector, confirming the binding. SiRNA-based deregulation of CFAP20DC-AS1 attenuated the expression of miR-3614-3p and . In contrast to CFAP20DC-AS1, miR-3614-3p was upregulated by Rh2, inhibiting proliferation but stimulating apoptosis of the MCF-7 cells. Target genes of miR-3614-3p, BBX and TNFAIP3, were downregulated by Rh2 and the miRNA but upregulated by the lncRNA. Rh2 inhibits CFAP20DC-AS1, which obscures the association of the lncRNA with miR-3614-3p, resulting in the suppression of oncogenic BBX and TNFAIP3. Taken together, the Rh2/CFAP20DC-AS1/miR-3614-3p/target gene axis contributes to the antiproliferation activity of Rh2 in cancer cells.

摘要

虽然许多编码基因已经解释了人参皂苷 Rh2 的抗癌活性,但对于非编码 RNA 知之甚少。本研究旨在阐明长链非编码 RNA (lncRNA) CFAP20DC-AS1 的调节活性,已知 Rh2 下调 CFAP20DC-AS1 的表达。使用 LncBase Predicted 程序筛选可能与 CFAP20DC-AS1 结合的 miR-3614-3p,并通过测定荧光素酶/lncRNA 重组质粒构建体的荧光素酶活性来验证结合。使用 siRNA 下调每种 RNA 后,通过定量 PCR 进一步验证了两种 RNA 的竞争内源性 RNA (ceRNA) 关系。在下调相应基因后,用 Rh2 监测 MCF-7 癌细胞生长中的增殖和凋亡,确定 miRNA 和靶基因对 MCF-7 癌细胞生长的影响。miRNA 降低了荧光素酶/CFAP20DC-AS1 融合载体的荧光素酶活性,证实了结合。基于 siRNA 的 CFAP20DC-AS1 下调减弱了 miR-3614-3p 的表达。与 CFAP20DC-AS1 相反,Rh2 上调 miR-3614-3p,抑制 MCF-7 细胞的增殖但刺激其凋亡。miR-3614-3p 的靶基因 BBX 和 TNFAIP3 被 Rh2 和 miRNA 下调,但被 lncRNA 上调。Rh2 抑制 CFAP20DC-AS1,从而掩盖了 lncRNA 与 miR-3614-3p 的关联,导致致癌基因 BBX 和 TNFAIP3 被抑制。总之,Rh2/CFAP20DC-AS1/miR-3614-3p/靶基因轴有助于 Rh2 在癌细胞中的抗增殖活性。

相似文献

1
Ginsenoside Rh2 Regulates the CFAP20DC-AS1/MicroRNA-3614-3p/BBX and TNFAIP3 Axis to Induce Apoptosis in Breast Cancer Cells.人参皂苷 Rh2 通过调控 CFAP20DC-AS1/miR-3614-3p/BBX 和 TNFAIP3 轴诱导乳腺癌细胞凋亡。
Am J Chin Med. 2022;50(6):1703-1717. doi: 10.1142/S0192415X22500720. Epub 2022 Jul 4.
2
Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation.人参皂苷Rh2上调长链非编码RNA STXBP5-AS1以吸附微小RNA-4425,从而抑制乳腺癌细胞增殖。
J Ginseng Res. 2021 Nov;45(6):754-762. doi: 10.1016/j.jgr.2021.08.006. Epub 2021 Aug 27.
3
LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.LncRNA LOXL1-AS1 通过调控 miR-143-3p 抑制乳腺癌细胞增殖、迁移和侵袭并诱导细胞凋亡。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10400-10409. doi: 10.26355/eurrev_201912_19679.
4
Ginsenoside Rh2 Suppresses Breast Cancer Cell Proliferation by Epigenetically Regulating the Long Noncoding RNA C3orf67-AS1.人参皂苷 Rh2 通过表观遗传调控长链非编码 RNA C3orf67-AS1 抑制乳腺癌细胞增殖。
Am J Chin Med. 2019;47(7):1643-1658. doi: 10.1142/S0192415X19500848. Epub 2019 Oct 23.
5
Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.长链非编码 RNA PTPRG-AS1/微小 RNA-124-3p 通过竞争性内源性 RNA 机制调控 LIM 同源盒 2 依赖性 Notch 通路调节鼻咽癌的放射敏感性。
Bioengineered. 2022 Apr;13(4):8208-8225. doi: 10.1080/21655979.2022.2037364.
6
Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells.MBNL1-AS1/miR-889-3p/KLF9 轴在人乳腺癌细胞中的抑瘤功能。
Cell Cycle. 2022 May;21(9):908-920. doi: 10.1080/15384101.2022.2034254. Epub 2022 Feb 3.
7
Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.长链非编码 RNA FAM83A 反义 RNA 1(lncRNA FAM83A-AS1)靶向 microRNA-141-3p 调控肺腺癌细胞增殖、迁移、侵袭和上皮间质转化进展。
Bioengineered. 2022 Mar;13(3):4964-4977. doi: 10.1080/21655979.2022.2037871.
8
The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.长链非编码 RNA MSC-AS1/miR-29b-3p 轴调控 CDK14 在胰腺癌增殖和吉西他滨诱导凋亡中的作用。
Cancer Biol Ther. 2019;20(6):729-739. doi: 10.1080/15384047.2018.1529121. Epub 2019 Mar 27.
9
LncRNA BBOX1-AS1 Contributes to the Progression of Esophageal Carcinoma by Targeting the miR-361-3p/COL5A1 Axis.LncRNA BBOX1-AS1 通过靶向 miR-361-3p/COL5A1 轴促进食管癌的进展。
Biochem Genet. 2023 Aug;61(4):1351-1368. doi: 10.1007/s10528-022-10307-3. Epub 2022 Dec 31.
10
LncRNA IGFL2-AS1 as a ceRNA Promotes HCT116 Cell Malignant Proliferation via the miR-433-3p/PAK4 Axis.长链非编码 RNA IGFL2-AS1 通过竞争性内源性 RNA 促进 HCT116 细胞恶性增殖 miR-433-3p/PAK4 轴。
Turk J Gastroenterol. 2023 May;34(5):497-507. doi: 10.5152/tjg.2023.21998.

引用本文的文献

1
Targeting the PI3K Pathway: Advancements and Achievements in Breast Cancer Therapy.靶向PI3K通路:乳腺癌治疗的进展与成果
Curr Pharm Des. 2025;31(31):2481-2503. doi: 10.2174/0113816128357976250122042633.
2
Human disease-related long noncoding RNAs: Impact of ginsenosides.人类疾病相关的长链非编码RNA:人参皂苷的影响
J Ginseng Res. 2024 Jul;48(4):347-353. doi: 10.1016/j.jgr.2024.04.002. Epub 2024 Apr 14.
3
Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review.更新人参皂苷在乳腺癌治疗中的作用:从文献计量学研究到深入综述
Front Pharmacol. 2023 Sep 25;14:1226629. doi: 10.3389/fphar.2023.1226629. eCollection 2023.
4
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer.人参皂苷:改变癌细胞的基本特征以达到治疗乳腺癌的目的。
Chin Med. 2023 Sep 25;18(1):125. doi: 10.1186/s13020-023-00822-9.
5
Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer.人参皂苷对乳腺癌的抗癌作用及潜在的微小RNA靶点
Front Pharmacol. 2022 Oct 5;13:1033017. doi: 10.3389/fphar.2022.1033017. eCollection 2022.